Search results
Nov 17, 2021 · The Health Sciences Authority (HSA) is aware of claims circulating on social media and in Telegram chat groups that Lianhua Qingwen (连花清瘟) products can be used to prevent or treat COVID-19.
Apr 19, 2022 · A clinical trial is under way to assess how Lianhua Qingwen capsules, a traditional Chinese medicine, may help speed up symptom recovery and negative ART test result in fully vaccinated adults with mild COVID-19. The study, initiated by the Singapore Chung Hwa Medical Institution, aims to provide evidence for TCM treatment of pandemic patients.
Lianhua Qingwen ( simplified Chinese: 连花清瘟; traditional Chinese: 連花清瘟; lit. 'medicine using Forsythia suspensa and Lonicera japonica to clear illness', [1] LHQW) is a traditional Chinese medicine (TCM) formulation used for the treatment of influenza. [2] .
Nov 17, 2021 · Lianhua Qingwen Capsule is locally registered as a proprietary Chinese medicine and this does not mean that the capsule can be used as a medicine to treat or relieve COVID-19 symptoms.
May 9, 2022 · Lianhua Qingwen Jiaonang (LHQW) 莲花清瘟胶囊 capsules are classified as Chinese Proprietary Medicines (CPMs) in Singapore, approved for the relief of cold and flu symptoms. CPMs are not intended for the prevention, treatment or cure of specific diseases.
Jun 3, 2022 · The traditional Chinese medicine formula Lianhua Qingwen (LQ) combined with western medicine therapy is beneficial to coronavirus disease-19 (COVID-19), but there is still a lack of strong evidence-based.
Jul 1, 2022 · Lianhua Qingwen (LHQW) has been widely used in China and overseas Chinese, which had some advantages in the treatment of COVID-19. Objective. To evaluate the efficacy and safety of LHQW for COVID-19 by conducting a systematic review with meta-analysis. Methods.
